GUGGENHEIM CAPITAL LLC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 199 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2015. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q2 2017$44,000
-42.9%
18,528
-13.7%
0.00%
Q1 2017$77,000
-8.3%
21,479
-9.0%
0.00%
Q4 2016$84,000
-19.2%
23,596
-8.1%
0.00%
Q3 2016$104,000
-18.1%
25,688
-10.6%
0.00%
Q2 2016$127,000
+3.3%
28,718
-11.5%
0.00%
Q1 2016$123,000
-97.4%
32,436
-89.5%
0.00%
-100.0%
Q4 2015$4,823,000
+10.4%
307,620
-25.8%
0.01%
+7.7%
Q3 2015$4,368,000
-51.2%
414,412
+16.6%
0.01%
-40.9%
Q2 2015$8,960,000
+20.4%
355,279
+33.0%
0.02%
+22.2%
Q1 2015$7,443,000
+45.7%
267,065
-4.6%
0.02%
+38.5%
Q4 2014$5,107,000
+55.5%
279,850
+10.4%
0.01%
+62.5%
Q3 2014$3,285,000
-6.6%
253,445
+17.6%
0.01%
-11.1%
Q2 2014$3,518,000
-16.5%
215,572
-9.6%
0.01%
-25.0%
Q1 2014$4,212,000
-11.2%
238,364
+21.7%
0.01%
-14.3%
Q4 2013$4,742,000
-16.4%
195,848
+22.4%
0.01%
-30.0%
Q3 2013$5,671,000
+88.5%
160,060
-16.9%
0.02%
+53.8%
Q2 2013$3,008,000192,7170.01%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2015
NameSharesValueWeighting ↓
KLP Enterprises, LLC 6,865,000$3,096,000100.00%
TSP Capital Management Group, LLC 698,674$1,549,0000.79%
Meditor Group Ltd 6,312,700$2,847,0000.61%
Telemetry Investments, L.L.C. 186,200$84,0000.04%
GSA CAPITAL PARTNERS LLP 1,270,500$573,0000.03%
Benchmark Capital Advisors 53,400$24,0000.02%
BOENNING & SCATTERGOOD, INC. 80,150$36,0000.01%
NJ State Employees Deferred Compensation Plan 80,000$36,0000.01%
Centiva Capital, LP 121,720$55,0000.01%
Overbrook Management Corp 48,611$22,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders